Lv51
1220 积分 2021-01-12 加入
Psoriasis
20天前
已完结
[Studies on the pharmacokinetics of amoxicillin after intravenous, intramuscular and oral administration (author's transl)]
1个月前
已关闭
Highly selective, allosteric inhibition of TYK2 with oral ESK-001 in patients with moderate-to-severe plaque psoriasis: Results from STRIDE, a 12-week, randomized, double-blinded, placebo-controlled, dose-ranging Phase 2 study
11个月前
已完结
A Review of Phase III and Long‐Term Data for Deucravacitinib for Plaque Psoriasis
11个月前
已完结
Outcomes of PASI and PASI components in two phase 3 trials of deucravacitinib in patients with moderate to severe plaque psoriasis
11个月前
已完结
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index
1年前
已完结
Indirect comparisons of the efficacy of biological agents in patients with active ankylosing spondylitis: a systematic review and meta-analysis
1年前
已完结
Two-Year Treatment Persistence of Guselkumab vs Other Biologics in Plaque Psoriasis Patients
1年前
已关闭
New Topical and Systemic Treatments for Atopic Dermatitis
1年前
已关闭
Stapokibart Rapidly and Consistently Improves the Clinical Signs Across All Body Regions in Adults With Moderate‐to‐Severe Atopic Dermatitis
1年前
已完结
皖公网安备34019202002308
